After US nod, EU, NZ too ready to discuss waiver of IPR on vaccines

After US nod, EU, NZ too ready to discuss waiver of IPR on vaccines The move, first proposed by India and South Africa in October, is seen to be critical to ramp up and democratise Covid-19 vaccine and drug production and increase access in developing and poor countries. For months, there was a stalemate as the proposal was opposed by developed countries. https://ift.tt/eA8V8J